Highlights from the Gastrointestinal and Genitourinary Cancer Conferences
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
Source: curetoday.com
Asco Gu24 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Asco Gu24. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Asco Gu24 Today - Breaking & Trending Today
Opdivo Misses Disease-Free Survival Goal in Kidney Cancer Trial
Opdivo failed to improve disease-free survival in patients with localized renal cell carcinoma at high risk of relapse, according to findings from CheckMate 914.
Source: curetoday.com
Adstiladrin Leads to Beneficial Outcomes in Some Bladder Cancers
Urinary minimal residual disease-negative status was related to preventing the return of cancer when certain patients with bladder cancer received Adstiladrin.
Source: curetoday.com
Many Patients Miss Out on Testing to Guide Prostate Cancer Treatment
Approximately 40% of patients with metastatic castration-resistant prostate cancer did not undergo certain types of tests that can be instrumental in treatment decisions.
Source: curetoday.com
Cabometyx, Tecentriq Combo Improves Time to Progression in mCRPC
Cabometyx plus Tecentriq led to improved progression-free survival compared with novel hormonal therapy in patients with metastatic castration-resistant prostate cancer.
Source: curetoday.com